Journal of Antivirals & Antiretrovirals

Journal of Antivirals & Antiretrovirals
Open Access

ISSN: 1948-5964

+1-947-333-4405

Editorial Board

Honglin Zhou
Executive Editor
Associate Director of Center for Resuscitation Science, University of Pennsylvania, USA

Limin Chen
Executive Editor
Lab manager and research scientist
Faculty of Medicine
Read Interview session with Limin Chen, University of Toronto, Canada

Mohamad Aljofan
Executive Editor, Monash University, Australia

Submit Manuscript

Journal Impact Factor 1.27*
Submit manuscript at http://www.editorialmanager.com/virology or send as an e-mail attachment to the Editorial Office at [email protected]

About the Journal

NLM ID: 101526954

Index Copernicus Value: 108.6
H-Factor: 4

The Journal of Antivirals & Antiretrovirals (JAA) paves the way to discovery and development of antiviral drugs, compounds, and clinical methods to prevent viral infections. Importantly, JAA provides the opportunity to inform researchers, clinicians, and others working in the field of antiviral drugs and therapies.

JAA is an internationally recognized journal for scientists involved in basic, applied, and clinical aspects of antiviral and antiretroviral research. It is known that many viruses emerge and re-emerge threatening both animal and human populations. Zoonotic viruses can cause extensive morbidity and mortality; however, preventive vaccines that provide protection are available for only a limited number of viruses.

The primary current therapeutic approach against viral diseases is to target viral components that are essential for replication. There are a number of disadvantages targeting viral components including the limited number of druggable viral targets because viruses have a small genome, as well as the rapid development of drug resistance. New drug therapies combine antivirals to increase efficacy and to avoid the development of drug resistant strains. These strategies are effective for viruses such as HIV, but clearly there is a need to expand our drug arsenal to address the wide diversity of viruses. This pathway relies on alternative strategies for drug discovery, such as examining the virus-host interface. 

Journal of Antivirals & Antiretrovirals is using Editorial Manager System for quality in review process. Editorial Manager is an online manuscript submission, review and tracking systems used by most of the best open access journals. Review processing is performed by the editorial board members of journal or outside experts; at least two independent reviewers approval followed by editor's approval is required for acceptance of any citable manuscript.

Authors are requested to submit manuscripts at http://www.editorialmanager.com/virology/ or send as an e-mail attachment to the Editorial Office at [email protected] 

Journal Highlights

Top